In:
Ethnicity & Disease, Ethnicity and Disease Inc, Vol. 32, No. 1 ( 2022-01-20), p. 61-68
Abstract:
Well-characterized disparities in clinical research have disproportionately affected patients of color, particularly in underserved communities. To tackle these barriers, Genentech formed the External Council for Advancing Inclusive Research, a 14-person committee dedicated to developing strategies to increase clinical research participation. To help improve the recruitment and retention of patients of color, this article chronicles our efforts to tangibly address the clinical research barriers at the system, study, and patient levels over the last four years. These efforts are one of the initial steps to fully realize the promise of personalized health care and provide increased patient benefit at less cost to society. Instead of simply acknowledging the problem, here we illuminate the collaborative and multilevel strategies that have been effective in delivering meaningful progress for patients.Ethn Dis. 2022;32(1):61-68; doi:10.18865/ed.32.1.61
Type of Medium:
Online Resource
ISSN:
1945-0826
,
1049-510X
Language:
Unknown
Publisher:
Ethnicity and Disease Inc
Publication Date:
2022
detail.hit.zdb_id:
2193738-2
Permalink